ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2052

The Prevalence and Pattern Of Self Reported Joint Symptoms In Cystic Fibrosis

Carl Orr1, Cormac McCarthy1, Johan Meurling1, Paul G. O'Connell2, Cedric Gunaratnam1,3 and Noel G McElvaney1, 1Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland, 2Rheumatology, Beaumont Hospital, Dublin, Ireland, 3Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Pulmonary Involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases II: Miscellaneous Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Arthritis in cystic fibrosis (CF) can be very incapacitating, and it is mainly of three types: CF arthritis, hypertrophic osteoarthropathy, and arthritis due to co-existent conditions and drug reactions [1]. Episodic arthritis occurring in patients with cystic fibrosis has been recognised [2]. However, although joint manifestations are common in children with cystic fibrosis (CF), they have received little attention in adults [3]. The prevalence of joint pain in the CF patients has been reported variously as:

 12.9% [4], 2-8.5% of patients [3] and 4.5% in patients aged over 10 [5]. Our experience suggested that the prevalence may be higher than that previously reported.

Methods:

Rheumatic symptoms and signs of 55 adult patients with CF (age 18 to 63 years) were determined by questionnaire and phone interview. The questionnaire was designed to elicit the pattern of joint problems, as well as to determine features of definite inflammatory problems which included joint swelling, difficulty with function (e.g. making a fist) and morning stiffness lasting greater than 1 hour.

Results:

63.6% (35/55) reported ever having experienced joint pain, but only 37.1% of those who reported experiencing pain at any point said that it had affected important activities in their lives. 16.4% (9/55) reported more than one hour of morning stiffness in their joints. 30.9% (17/55) reported joint swelling or difficulty making a fist.

In those that reported pain, 60% (21/35) reported wrist pain, with 42.9% (9/21) of these patients  reporting wrist swelling. 16.4% (9/55) of the total cohort had experienced both wrist pain and swelling.

In those that reported pain, 57.1% (20/35) reported hand pain, with 60% (12/20) reporting swelling and 65% (13/20) having difficulty making a fist. Inflammatory symptoms (difficulty making a fist or hand swelling) were reported in 80% (16/20) of those with hand pain.

Knee 80% (28/35), ankle 60% (21/35) and foot 31.4% (11/35) pain were cited by those reporting pain. 

Symmetrical disease in time was reported in 48.6% (17/35) patients.

Conclusion:

The prevalence of joint symptoms by self-report in our CF cohort far exceed that reported in previous studies. The age of the cohort would suggest that joint pain is being reported more commonly in patients with CF than in subjects of similar age who do not have CF.

The reported symptoms of swelling and morning stiffness suggest that the problems may be inflammatory in up to 30% of patients with CF.

No definite pattern of involvement could be identified in this study.

References:

1.            Parasa, R.B. and N. Maffulli, Musculoskeletal involvement in cystic fibrosis. Bulletin-Hospital for Joint Diseases, 1999. 58(1): p. 37-44.

2.            Johnson, S. and A. Knox, Arthropathy in cystic fibrosis. Respiratory medicine, 1994. 88(8): p. 567-570.

3.            Botton, E., et al., Musculoskeletal manifestations in cystic fibrosis. Joint Bone Spine, 2003. 70(5): p. 327-335.

4.            Koch, A.-K., et al., Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF)—no observations of CF-specific arthropathy. The Journal of Rheumatology, 2008. 35(9): p. 1882-1891.

5.            Pertuiset, E., et al., Cystic fibrosis arthritis. A report of five cases. Rheumatology, 1992. 31(8): p. 535-538.


Disclosure:

C. Orr,
None;

C. McCarthy,
None;

J. Meurling,
None;

P. G. O’Connell,
None;

C. Gunaratnam,
None;

N. G. McElvaney,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prevalence-and-pattern-of-self-reported-joint-symptoms-in-cystic-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology